Abstract:Context: Psoriasis is a chronic, inflammation-mediated skin disease. The use of traditional Chinese medicine (TCM) in the treatment of psoriasis boasts a rich historical tradition. Researchers widely use network pharmacology to reveal the action mechanisms of TCM by establishing an interaction network-drug-component-target-disease. Objective: The study aimed to use a network pharmacology approach to investigate the interaction between TCM and its targets in psoriasis, aiming to identify core drugs and mechanisms underlying TCM's treatment of common psoriasis and to create a new TCM formula. Design: The research team performed a retrospective genetic study. Setting: The study took place in the Dermatology Department at Beijing Wangfu Hospital of Integrative Medicine in Beijing, China. Participants: Participants were patients that the dermatology clinic had diagnosed with common psoriasis between January 1, 2016 and January 1, 2019. Outcome measures: The research team: (1) calculated the frequency of each herb's occurrence; (2) identified the core drugs; (3) determined the core drugs' active ingredients and targets; (4) identified psoriasis' targets; (5) determined the target proteins; (6) identified the top-30, key signaling-set pathways; (7) identified the top 10 biological processes (BPs), cell components (CC), and molecular functions (MF); (8) screened the top-five major active ingredients; and (9) performed molecular docking. Results: The research team: (1) based on 892 prescriptions from 95 patients, identified 161 herbal medicines, with Lonicerae Japonicae Flos, Herba Portulacae, Radix Gentianae, Bletilla striata, Raw Rehmanniae Radix, Dictamni Cortex, and Forsythia suspensa being core drugs; (2) found 58 active ingredients and 144 effective, target functional genes for the core drugs through network pharmacology screening, with 81 potential targets for psoriasis treatment; the core drugs for treatment may restore the keratin-forming cell function by inhibiting cancer-related pathways, the interleukin-17 (IL-17) signaling pathway, the tumor necrosis factor (TNF) signaling pathway, and the hypoxia-inducible factor-1 (HIF-1) signaling pathway; (3) using molecular docking, revealed high-affinity interactions between the active ingredients primuletin, luteolin, and wogonin and mitogen-activated protein kinase 8 (MAPK8), tumor protein 53 (TP53), and epidermal growth factor receptor (EGFR). Conclusions: The new TCM formula to be used in the current research team's hospital may act on MAPK8, TP53, and EGFR targets through active ingredients such as primuletin, kaempferol, luteolin, wogonin, and β-sitosterol, which involve several signaling pathways, such as the cancer signaling, TNF signaling pathway, HIF-1 signaling pathway, and endocrine resistance. The research provides a theoretical foundation for the clinical use of the new TCM formula.

Novel Psoriasis Treatment: Development and Evaluation of a Thermo-Sensitive Pro-Penetrating Hydrogel Based on Coptis chinensis and Phellodendron amurense

A Novel Methacryloyl Chitosan Hydrogel Microneedles Patch with Sustainable Drug Release Property for Effective Treatment of Psoriasis

Advances in the Application of Natural Products and the Novel Drug Delivery Systems for Psoriasis

Development of a Deep Eutectic Solvent-Assisted Kaempferol Hydrogel: A Promising Therapeutic Approach for Psoriasis-like Skin Inflammation

Phellodendri Chinensis Cortex-Based Nanoparticles Integrated in Dissolvable Microneedles for Ameliorating Psoriasis-Like Inflammation

Curcumin-Based Ionic Liquid Hydrogel for Topical Transdermal Delivery of Curcumin To Improve Its Therapeutic Effect on the Psoriasis Mouse Model

Betulin-NLC-hydrogel for the Treatment of Psoriasis-like Skin Inflammation: Optimization, Characterisation, and In vitro and In vivo Evaluation

Shikonin-loaded PLGA nanoparticles: A promising strategy for psoriasis treatment

Network Pharmacology Analysis of Traditional Chinese Medicine for Treating Psoriasis: Identifying Core Components, Mechanisms, and Dosing Patterns

Dermal Delivery of Hypericum perforatum (L.) Loaded Nanogel: Formulation to Preclinical Psoriasis Assessment

Calcipotriol Nanosuspension-Loaded Trilayer Dissolving Microneedle Patches for the Treatment of Psoriasis: In Vitro Delivery and In Vivo Antipsoriatic Activity Studies

A transdermal delivery system using microneedle patches containing poly(lactic-co-glycolic)-encapsulated acitretin nanoparticles for topical and extended treatment

Transdermal Delivery of Therapeutic Compounds With Nanotechnological Approaches in Psoriasis

Microneedle patches incorporating zinc-doped mesoporous silica nanoparticles loaded with betamethasone dipropionate for psoriasis treatment

Water-responsive gel extends drug retention and facilitates skin penetration for curcumin topical delivery against psoriasis

Mesoporous silica-based nanocarriers with dual response to pH and ROS for enhanced anti-inflammation therapy of 5-Demethylnobiletin against psoriasis-like lesions

Percutaneous Delivery of Hederacoside C-Loaded Nanoliposome Gel Alleviates Psoriasiform Skin Inflammation through the CCL17/Treg Axis

Foamed Microemulsion Nanodroplets Loaded with Chlorin E6 for Epidermal-Targeted Treatment Against Psoriasis

Optimization, In Vitro and Ex Vivo Assessment of Nanotransferosome Gels Infused with a Methanolic Extract of Solanum xanthocarpum for the Topical Treatment of Psoriasis

Potential effects and mechanisms of Chinese herbal medicine in the treatment of psoriasis

Microneedle-assisted percutaneous delivery of methotrexate-loaded nanoparticles enabling sustained anti-inflammatory effects in psoriasis therapy